Glucose-dependent Insulinotropic Peptide (GIP) is a 42 amino acid peptide synthesized and secreted largely from endocrine cells in the small intestine. We propose that GIP modulates bone formation and resorption in response to nutrient uptake. The documented actions of GIP imply an important role in coupling food intake and absorption in the intestine with metabolic events in a number of tissues. Our observations support a role for GIP in modulating bone cell function, since GIP receptors localize to osteoblasts, osteoblast-like cells, osteoclasts, and osteocytes. Furthermore, GIP dose dependently increases intracellular cAMP and calcium contents in the osteoblast-like cell line SaOS, and stimulates alkaline phosphatase activity, collagen synthesis, and inhibits osteoclast-induced bone resorption. Based on these in vitro findings, we propose that GIP may act as a link between the nutritional state of the organism and the balance between bone formation and resorption. To evaluate further the hypothesis that GIP is anabolic for bone, we propose to define the effects of GIP on bone mass and bone turnover in vivo, both in a genetic model of GIP overexpression in transgenic mice, and in GIP receptor knock-out mouse model. As a first test of the hypothesis, GIP receptor knock-out mice will be analyzed for bone phenotypic changes, with specific reference to bone density and bone histomorphometric indices. In addition, the role of GIP-induced inhibition of osteoclastic bone resorption in the observed increases in bone mass induced by GIP will be studied in transgenic mice overexpressing GIP. These in vivo approaches are designed to test directly whether GIP can modulate bone formation and turnover. With the establishment of a genetic system, we hope to define the role of GIP in normal bone physiology. Should the in vivo findings support the profound influence of GIP on cultured osteblastoid cells, this would establish GIP as a potential link between food intake and bone metabolism. This in turn may signal GIP as a potential hormone target for pharmacologic intervention in bone pathologies such as osteoporosis. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK058680-04S1
Application #
7285906
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Malozowski, Saul N
Project Start
2003-04-15
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2008-03-31
Support Year
4
Fiscal Year
2006
Total Cost
$41,068
Indirect Cost
Name
Georgia Health Sciences University
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
966668691
City
Augusta
State
GA
Country
United States
Zip Code
30912
Mi, Qing-Sheng; Yan, Sheng-Li; Wang, Zai-Zhao et al. (2009) Spontaneous bone loss in RIP-iNOS transgenic mouse: a mouse model for diabetes-mediated osteopenia/osteoporosis. Cell Cycle 8:4179-81
Zhang, Weixi; Ou, Guomin; Hamrick, Mark et al. (2008) Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J Bone Miner Res 23:1118-28
Ding, Ke-Hong; Shi, Xing-Ming; Zhong, Qing et al. (2008) Impact of glucose-dependent insulinotropic peptide on age-induced bone loss. J Bone Miner Res 23:536-43
Zhong, Qing; Itokawa, Takashi; Sridhar, Supriya et al. (2007) Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab 292:E543-8
Hamrick, M W; Shi, X; Zhang, W et al. (2007) Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 40:1544-53
Isales, Carlos M (2007) Role of the oral and maxillofacial surgeon in the diagnosis and treatment of patients with osteoporosis. Oral Maxillofac Surg Clin North Am 19:475-85, v
Isales, Carlos M; McDonald, Jay M (2007) Future developments in therapy. Ann N Y Acad Sci 1117:258-63
Xie, Ding; Zhong, Qing; Ding, Ke-Hong et al. (2007) Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass. Bone 40:1352-60
Hamrick, Mark W; Ding, Ke-Hong; Pennington, Catherine et al. (2006) Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin. Bone 39:845-53
Ding, Ke-Hong; Zhong, Qing; Xie, Ding et al. (2006) Effects of glucose-dependent insulinotropic peptide on behavior. Peptides 27:2750-5

Showing the most recent 10 out of 13 publications